News and Trends 22 Oct 2014
New Treatment against critic Leukemia Approved In Europe
Janssen's Imbruvica (ibrutinib), the once-daily oral Bruton's tyrosine kinase (BTK) inhibitor, has been approved in Europe as a treatment for two blood cancers. The drug has been ratified by the European…